Estadísticas
Número total de visitas
| Visualizaciones | |
|---|---|
| Clinical Effectiveness and Safety of Once-Weekly GLP-1 Receptor Agonist Dulaglutide as Add-On to Metformin or Metformin Plus Insulin Secretagogues in Obesity and Type 2 Diabetes | 93 |
Visitas al mes
| enero 2024 | febrero 2024 | marzo 2024 | abril 2024 | mayo 2024 | junio 2024 | julio 2024 | |
|---|---|---|---|---|---|---|---|
| Clinical Effectiveness and Safety of Once-Weekly GLP-1 Receptor Agonist Dulaglutide as Add-On to Metformin or Metformin Plus Insulin Secretagogues in Obesity and Type 2 Diabetes | 4 | 0 | 5 | 2 | 2 | 6 | 0 |
Visitas al fichero
| Visualizaciones | |
|---|---|
| jcm-10-00985.pdf | 128 |
Países con más visualizaciones
| Visualizaciones | |
|---|---|
| Estados Unidos | 51 |
| China | 7 |
| Hong Kong | 6 |
| España | 5 |
| Irlanda | 4 |
| Singapur | 3 |
| Ucrania | 3 |
| Grecia | 2 |
| Rusia | 2 |
| Alemania | 1 |
Ciudades con más visualizaciones
| Visualizaciones | |
|---|---|
| San Ramon | 9 |
| Fairfield | 7 |
| Ashburn | 6 |
| Dublin | 4 |
| Hangzhou | 3 |
| Menlo Park | 3 |
| Montilla | 3 |
| Mountain View | 3 |
| Redwood City | 3 |
| Singapore | 3 |